Monoketo (Ketotifen Hydrogen Fumarate)

Ketotifen blocks H1 histamine receptors on ocular cells and stabilizes mast cells, preventing the release of histamine and other inflammatory mediators. This dual action reduces vascular leakage, edema, and nerve irritation that produce itching, redness, and tearing.

The dosing regimen for Monoketo is determined by the prescribing eye‑care professional. Typically, one or two drops are instilled in the affected eye(s) as directed, but the exact frequency and duration should follow the prescriber’s instructions.

Safety data for ketotifen eye drops in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Monoketo.

To order Monoketo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Monoketo combines antihistamine and mast‑cell‑stabilizing actions in a single ophthalmic formulation, offering both rapid symptom relief and longer‑term control. Alternative treatments may include separate antihistamine drops, mast‑cell stabilizers, or non‑steroidal anti‑inflammatory eye drops, each with distinct efficacy and safety profiles.

Monoketo should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed in its original packaging, and avoid freezing. Discard any solution that appears discolored or contains particles.

Monoketo is applied topically to the eye. After washing hands, tilt the head back, pull down the lower eyelid, and place the prescribed number of drops into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few seconds to allow absorption.

Serious but rare risks include allergic reactions such as eyelid swelling, rash, or severe eye irritation, as well as corneal ulceration or significant visual disturbances. If any of these occur, discontinue use immediately and seek urgent medical attention.

Monoketo should not be used by individuals with a known hypersensitivity to ketotifen or any component of the formulation. It is also contraindicated in patients who have active ocular infections or severe ocular surface disease unless advised by an eye‑care specialist.